Thrombosis of the internal jugular vein in the ENT-department — Prevalence, causes and therapy: A retrospective analysis

Hahn, Janina; Nordmann-Kleiner, Melanie; Hoffmann, Thomas; Greve, Jens

doi:10.1016/j.anl.2018.11.009

Cited by 18 publications

(15 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ultrasonography of the neck, which can be completed by computed tomography angiography or magnetic resonance imaging with angiography, is indicated in cases of neck thrombosis, especially in cases of internal jugular vein thrombosis [67].…”

Section: Clinical Practice and Recommendationsmentioning

confidence: 99%

See 1 more Smart Citation

Thrombosis Risk Associated with Head and Neck Cancer: A Review

Haen

Mège

Crescence

et al. 2019

IJMS

View full text Add to dashboard Cite

Venous thromboembolism (VTE) is a common complication for cancer patients. VTE-associated risk varies according to the type of tumor disease. Head and neck cancer is a common cancer worldwide, and most tumors are squamous cell carcinomas due to tobacco and alcohol abuse. The risk of VTE associated with head and neck (H&N) cancer is considered empirically low, but despite the high incidence of H&N cancer, few data are available on this cancer; thus, it is difficult to state the risk of VTE. Our review aims to clarify this situation and tries to assess the real VTE risk associated with H&N cancer. We report that most clinical studies have concluded that there is a very low thrombosis risk associated with H&N cancer. Even with the biases that often exist, this clinical review seems to confirm that the risk of VTE was empirically hypothesized. Furthermore, we highlight that H&N cancer has all the biological features of a cancer associated with a high thrombosis risk, including a strong expression of procoagulant proteins, modified thrombosis/fibrinolysis mechanisms, and secretions of procoagulant microparticles and procoagulant cytokines. Thus, this is a paradoxical situation, and some undiscovered mechanisms that could explain this clinical biological ambivalence might exist.

show abstract

Section: Clinical Practice and Recommendationsmentioning

confidence: 99%

“…Incidentally discovered VTE must be treated similarly [69]. The same treatment would also be indicated for neck vein thrombosis [67].…”

Section: Clinical Practice and Recommendationsmentioning

confidence: 99%

Thrombosis Risk Associated with Head and Neck Cancer: A Review

Haen

Mège

Crescence

et al. 2019

IJMS

View full text Add to dashboard Cite

show abstract

“…5 Bandara et al 6 reported that hidden malignancy should be investigated in patients with spontaneous IJV thrombosis. In a study conducted on IJV thrombosis involving 41 cases conducted by Hahn et al, 7 the cause was found to be malignancy in 22 (53.6%) patients, inflammatory diseases such as cervical abscess in 14 (34.1%) patients, and insertion of a central venous catheter in 2 (4.8%) patients, while no cause was identified in 3 (7.3%) patients. In our patient, we examined for malignancy in the entire body, but could not find any malignancy.…”

Section: Discussionmentioning

confidence: 97%

Internal Jugular Vein Thrombosis due to Chronic Kidney Disease: A Case Report

Kara

2020

Annals of Vascular Surgery

View full text Add to dashboard Cite

“…Most IJV thromboses are secondary to central catheter or pacemaker placement, extrinsic compression (by a tumor or malformation), local infections (e.g., Lemierre disease), cervical trauma, or ENT cancer. Unprovoked IJV thrombosis is uncommon and has been associated with paraneoplastic disease, thrombophilia, OHS, and idiopathic IJV [10,26,[49][50][51]. OHS is associated with thromboembolic complications, but their mechanisms are incompletely understood [52].…”

Section: Internal Jugular Vein Thrombosis Epidemiologymentioning

confidence: 99%

Unprovoked internal jugular vein thrombosis: a case report and literature review

et al. 2021

View full text Add to dashboard Cite

Background Managing thrombosis in rare sites is challenging. Existing studies and guidelines provide detailed explanations on how to overcome lower-limb thromboses and pulmonary embolisms, but few studies have examined thrombosis in rare sites. Lack of data makes clinical practice heterogeneous. Recommendations for diagnosing, treating, and following-up internal jugular vein thrombosis are not clearly defined and mostly based on adapted guidelines for lower-limb thrombosis. Case presentation A 52-year-old Caucasian woman came to the Emergency Department with chest, neck, and left arm pain. Computed tomography imagery showed a left internal jugular vein thrombosis. An extensive workup revealed a heterozygous factor V Leiden gene. Therapy was initiated with intravenous unfractionated heparin, then switched to oral acenocoumarol, which resolved the symptoms. Based on this case presentation and a literature review, we summarize the causes, treatment options, and prognosis of unprovoked internal jugular vein thrombosis. Conclusions Managing internal jugular vein thrombosis lacks scientific data from large randomized clinical trials, partly because such thromboses are rare. Our literature review suggested that clinical treatments for internal jugular vein thrombosis often followed recommendations for treating lower-limb thrombosis. Future specific studies are required to guide clinicians on the modalities of diagnosis, screening for thrombophilia or oncologic disease, treatment duration, and follow-up.

show abstract

Thrombosis of the internal jugular vein in the ENT-department — Prevalence, causes and therapy: A retrospective analysis

Cited by 18 publications

References 11 publications

Thrombosis Risk Associated with Head and Neck Cancer: A Review

Thrombosis Risk Associated with Head and Neck Cancer: A Review

Internal Jugular Vein Thrombosis due to Chronic Kidney Disease: A Case Report

Unprovoked internal jugular vein thrombosis: a case report and literature review

Contact Info

Product

Resources

About